Background: New guidelines in the treatment of acute ischemic stroke include timely recognition of stroke symptoms and evaluation for rapid treatment of stroke with IV t-PA administration and endovascular intervention. Methods: The DNP student/project coordinator led a collaborative effort to integrate the updated AHA/ASA ischemic stroke guideline through revision of the current in-house stroke algorithm; facilitation of the implementation plan; and evaluation of the implementation plan. Evaluation: The DNP student/project coordinator suggested an evaluation of the practice change through monthly discussion of algorithm fall-outs at the Stroke Committee meetings at the hospital. Significance and Implications: Implementation of this project ...
BACKGROUND: Tissue plasminogen activator (tPA) treatment for acute ischaemic stroke (AIS) should ...
Background: Stroke is a leading cause of death and disability internationally. One of the three effe...
Objective: To reveal the profile and practice in patients with acute stroke who received intravenous...
Background and Purpose-Thrombolysis with intravenous recombinant tissue plasminogen activator is an ...
Abstract Problem: Decreasing the time to assess acute ischemic stroke patients impacts the patients’...
Background and Purpose— Only a small minority of acute stroke patients receive approved acute stroke...
Stroke medicine has seen rapid developments in diagnosis and management, and consequently improved p...
Background: Stroke is the third leading cause of death in the United States with an average of one s...
© 2019 The Canadian Journal of Neurological Sciences Inc. After five positive randomized controlled ...
Background: Stroke is an abrupt onset of a neurologic deficit due to a focal vascular disease. Treat...
Rapid response treatment protocol · Acute onset ischemic stroke · Intravenous thrombolysis Aims: Thi...
Background: The Thrombolysis ImPlementation in Stroke (TIPS) trial tested the effect of a multicompo...
Protracted and partial implementation of treatment with intravenous tissue plasminogen activator (tP...
Background: Stroke is a leading cause of death and disability internationally. One of the three effe...
As stroke is still the leading cause of disability and mortality worldwide, it is promising that the...
BACKGROUND: Tissue plasminogen activator (tPA) treatment for acute ischaemic stroke (AIS) should ...
Background: Stroke is a leading cause of death and disability internationally. One of the three effe...
Objective: To reveal the profile and practice in patients with acute stroke who received intravenous...
Background and Purpose-Thrombolysis with intravenous recombinant tissue plasminogen activator is an ...
Abstract Problem: Decreasing the time to assess acute ischemic stroke patients impacts the patients’...
Background and Purpose— Only a small minority of acute stroke patients receive approved acute stroke...
Stroke medicine has seen rapid developments in diagnosis and management, and consequently improved p...
Background: Stroke is the third leading cause of death in the United States with an average of one s...
© 2019 The Canadian Journal of Neurological Sciences Inc. After five positive randomized controlled ...
Background: Stroke is an abrupt onset of a neurologic deficit due to a focal vascular disease. Treat...
Rapid response treatment protocol · Acute onset ischemic stroke · Intravenous thrombolysis Aims: Thi...
Background: The Thrombolysis ImPlementation in Stroke (TIPS) trial tested the effect of a multicompo...
Protracted and partial implementation of treatment with intravenous tissue plasminogen activator (tP...
Background: Stroke is a leading cause of death and disability internationally. One of the three effe...
As stroke is still the leading cause of disability and mortality worldwide, it is promising that the...
BACKGROUND: Tissue plasminogen activator (tPA) treatment for acute ischaemic stroke (AIS) should ...
Background: Stroke is a leading cause of death and disability internationally. One of the three effe...
Objective: To reveal the profile and practice in patients with acute stroke who received intravenous...